New perspectives in pulmonary arterial hypertension treatment: 2009 European recommendations

Pulmonary arterial hypertension (PAH) is one of the most severe cardiovascular disorders. It is characterised by progressing clinical course, right ventricular failure development, and very poor prognosis. In September 2009, the European Society of Cardiology and the European Respiratory Society rel...

全面介紹

書目詳細資料

發表在:	Кардиоваскулярная терапия и профилактика
Main Authors:	T. V. Martynyuk, S. N. Nakonechnikov, I. E. Chazova
格式:	Article
語言:	俄语
出版:	«SILICEA-POLIGRAF» LLC 2010-04-01
主題:	pulmonary arterial hypertension calcium antagonists anticoagulants diuretics endothelin receptor antagonists prostanoids phosphodiesterase 5 inhibitors
在線閱讀:	https://cardiovascular.elpub.ru/jour/article/view/2048